Aug 27, 2026 02:00AM
Aug 27, 2026 02:00AM
Aug 4, 2026 04:01PM
Jul 1, 2026 08:48AM
Jun 8, 2026 02:56AM
Jun 7, 2026 04:45PM
Jun 3, 2026 09:01AM AMGEN presents data on rare disease drugs at european medical congress
Jun 3, 2026 09:00AM
May 15, 2026 03:50PM
May 13, 2026 08:30AM
May 11, 2026 08:30AM
Apr 30, 2026 04:01PM
Apr 30, 2026 04:01PM
Apr 28, 2026 01:46PM AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring
Apr 6, 2026 09:00AM
Apr 6, 2026 09:00AM
Apr 1, 2026 07:30AM
Apr 1, 2026 07:30AM
Mar 31, 2026 03:14PM
Mar 28, 2026 04:45PM
Mar 9, 2026 10:53AM FDA: 'The agency today is withdrawing final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product'
Mar 3, 2026 05:31PM
Feb 16, 2026 05:31PM
Feb 3, 2026 04:01PM
Dec 22, 2025 07:06AM
Dec 21, 2025 08:00PM
Dec 11, 2025 06:10PM
Dec 11, 2025 06:09PM FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
Dec 4, 2025 08:30AM
Nov 19, 2025 04:02PM
Nov 19, 2025 04:01PM
Nov 8, 2025 10:15AM
Nov 8, 2025 10:15AM
Nov 4, 2025 04:01PM
Oct 31, 2025 09:00AM AMGEN to present Repatha trial data at heart association meeting
Oct 31, 2025 09:00AM
Oct 17, 2025 04:11PM
Oct 17, 2025 04:00PM
Oct 17, 2025 04:00PM
Oct 2, 2025 09:00AM
Oct 2, 2025 09:00AM
Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
Oct 1, 2025 01:13PM
Sep 10, 2025 09:16AM
Sep 9, 2025 12:13AM
Sep 9, 2025 12:12AM
Sep 8, 2025 08:04PM
Sep 8, 2025 08:04PM
Aug 25, 2025 09:03AM FDA expands AMGEN's Repatha approval for cardiovascular risk reduction
Aug 25, 2025 09:00AM

329,502 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All